(Q35167427)

6 August 2017

1 reference

title

How best to estimate the global burden of pertussis? (English)

1 reference

6 August 2017

N S Crowcroft

1

1 reference

6 August 2017

C Stein

series ordinal

2

1 reference

6 August 2017

P Duclos

series ordinal

3

1 reference

6 August 2017

M Birmingham

series ordinal

4

1 reference

6 August 2017

publication date

1 July 2003

1 reference

Lancet Infectious Diseases

6 August 2017

published in

1 reference

6 August 2017

volume

3

1 reference

6 August 2017

issue

7

1 reference

6 August 2017

page(s)

413-418

1 reference

Pertussis transmission in England and Wales

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900669-8

7 January 2021

Age-specific efficacy of pertussis vaccine during epidemic and non-epidemic periods

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900669-8

7 January 2021

The efficiency of measles and pertussis notification in England and Wales.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900669-8

7 January 2021

An age-structured model for pertussis transmission

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900669-8

7 January 2021

Comparative efficacy of acellular pertussis vaccines: an analysis of recent trials

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900669-8

7 January 2021

Practice guidelines developed by specialty societies: the need for a critical appraisal

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900669-8

7 January 2021

Persistence of pertussis in an immunized population: results of the Nova Scotia Enhanced Pertussis Surveillance Program

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900669-8

7 January 2021

Epidemiological features of pertussis in the United States, 1980-1989.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900669-8

7 January 2021

Changing epidemiology of pertussis in the United States: increasing reported incidence among adolescents and adults, 1990-1996

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900669-8

7 January 2021

Pertussis surveillance in Switzerland, 1992 to 1997 - a large epidemic in 1994. What next?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900669-8

7 January 2021

Pertussis in Sweden after the cessation of general immunization in 1979.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900669-8

7 January 2021

A placebo-controlled trial of a pertussis-toxoid vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900669-8

7 January 2021

Epidemiology of pertussis in Denmark: the impact of herd immunity.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900669-8

7 January 2021

Evidence for transmission of pertussis in schools, Massachusetts, 1996: epidemiologic data supported by pulsed-field gel electrophoresis studies

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900669-8

7 January 2021

Bordetella pertussis surveillance in England and Wales: 1995-7

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900669-8

7 January 2021

Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900669-8

7 January 2021

Persistence of protection through 33 months of age provided by immunization in infancy with two three-component acellular pertussis vaccines. Stage II Working Group

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900669-8

7 January 2021

Reemergence of pertussis in the highly vaccinated population of the Netherlands: observations on surveillance data

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900669-8

7 January 2021

Randomised controlled trial of two-component, three-component, and five-component acellular pertussis vaccines compared with whole-cell pertussis vaccine. Ad Hoc Group for the Study of Pertussis Vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900669-8

7 January 2021

Whooping Cough in Uganda

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900669-8

7 January 2021

Epidemiology of pertussis in a West African community before and after introduction of a widespread vaccination program

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900669-8

7 January 2021

The Butajira Rural Health Project in Ethiopia: Mortality Pattern of the Under Fives

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900669-8

7 January 2021

Deaths from pertussis are underestimated in England

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900669-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900669-8

1 reference

7 January 2021

Whooping cough--a continuing problem

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900669-8

7 January 2021

10.1016/S1473-3099(03)00669-8

Identifiers

DOI

1 reference

6 August 2017

1 reference